The effects of labetalol and prazosin on exercise haemodynamics in hypertensive patients.
The antihypertensive and haemodynamic effects of labetalol were compared with those of prazosin both at rest and during bicycle exercise in 38 moderate to moderately severe hypertensive patients (supine DBP 95 to 119 mmHg when untreated). Following a two week open placebo phase to establish baseline BP and baseline exercise performance, patients were randomly and double-blindedly assigned to receive labetalol or prazosin. Drug dose was titrated from 100 to 400 mg labetalol twice daily, or from one to 10 mg prazosin twice daily at weekly intervals until BP was controlled (supine DBP less than or equal to 90 mmHg with at least a 10 mmHg decrease from baseline). Eighteen labetalol and twenty prazosin patients achieved BP control and were subsequently reexercised to fatigue on a bicycle ergometer. The mean changes from baseline for heart rate and rate pressure product (heart rate x SBP) were reduced only in the labetalol group; the difference between the labetalol and prazosin groups was significant (P less than 0.01) both at rest and during exercise. This haemodynamic profile of labetalol may be important in selecting a vasodilating antihypertensive for patients with concomitant ischaemic heart disease.
Feit
A
A
Department of Medicine, State University of New York Health Science Center, Brooklyn 11203.
Cohen
M
M
Dimino
L
L
el-Sherif
N
N
Holtzman
R
R
Venkata
C
C
Ram
S
S
Gaffeny
D
D
Heller
J
J
Kaplan
N
N
D000328:Adult; D000368:Aged; D005260:Female; D006261:Headache / Q000139:chemically induced; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007741:Labetalol / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D005082:Physical Exertion; D011224:Prazosin / Q000009:adverse effects / Q000627:therapeutic use*
D007741:Labetalol; D011224:Prazosin